Vir Biotechnology, Inc.

NasdaqGS:VIR Stock Report

Market Cap: US$1.5b

Vir Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:VIR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 May 26SellUS$221,025Vicki SatoIndividual22,000US$10.05
17 Nov 25SellUS$37,782Jason O'ByrneIndividual6,799US$5.56
03 Nov 25SellUS$8,003Vanina de VerneuilIndividual1,365US$5.86
15 Jul 25SellUS$37,162Mark EisnerIndividual6,796US$5.47

Insider Trading Volume

Insider Buying: VIR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VIR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,0000.00593%
State or Government44,5380.0264%
Individual Insiders7,404,2404.39%
General Public20,322,66112.1%
VC/PE Firms32,415,71019.2%
Institutions108,454,82564.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22%.

Top Shareholders

Top 25 shareholders own 64.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
BlackRock, Inc.
17,998,329US$155.0m10.2%no data
7.66%
Arch Venture Partners, L.P.
12,916,663US$111.2m0%10.35%
6.49%
SB Investment Advisers (UK) Limited
10,948,093US$94.3m-16.5%0.71%
5.46%
Vanguard Portfolio Management, LLC
9,215,577US$79.3m0%no data
5.07%
GSK Equity Investments, Limited
8,550,954US$73.6m0%7.52%
4.23%
State Street Global Advisors, Inc.
7,141,094US$61.5m14.6%no data
3.19%
Vanguard Capital Management, LLC
5,382,103US$46.3m0%no data
2.24%
George Scangos
3,777,778US$32.5m0%no data
1.85%
The Goldman Sachs Group, Inc.
3,123,673US$26.9m109%0.01%
1.63%
ADAR1 Capital Management, LLC
2,744,714US$23.6m0%1.45%
1.58%
Geode Capital Management, LLC
2,657,843US$22.9m14.2%no data
1.53%
Dimensional Fund Advisors LP
2,579,678US$22.2m1.71%no data
1.33%
Morgan Stanley
2,245,192US$19.3m8.41%no data
1.24%
Citadel Advisors LLC
2,098,476US$18.1m329%0.01%
1.23%
FMR LLC
2,071,287US$17.8m-34.4%no data
1.19%
Soleus Capital Management, L.P.
2,002,000US$17.2m0%0.6%
1.16%
Point72 Asset Management, L.P.
1,952,234US$16.8m897%0.03%
1.11%
Boxer Capital Management, LLC
1,866,000US$16.1m199%1.82%
0.9%
GordonMD Global Investments LP
1,518,552US$13.1m63.2%8.48%
0.89%
Sio Capital Management, LLC
1,498,620US$12.9m213%1.8%
0.88%
Pictet Asset Management Limited
1,480,828US$12.7m10,900%0.01%
0.87%
Hudson Bay Capital Management LP
1,469,510US$12.7m10.9%0.08%
0.86%
Jacobs Levy Equity Management Inc
1,442,336US$12.4m0%0.04%
0.85%
Two Sigma Investments, LP
1,439,494US$12.4m144%0.01%
0.74%
Qube Research & Technologies Ltd
1,248,669US$10.8m1,400%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/15 05:34
End of Day Share Price 2026/06/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vir Biotechnology, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Huidong WangBarclays
Etzer DaroutBarclays